| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | heparan sulfate 6-O-sulfotransferase activity | 1.86e-07 | 3 | 115 | 3 | GO:0017095 | |
| GeneOntologyMolecularFunction | small GTPase binding | DOCK1 BICDL2 ERC1 TRIP11 XPO5 ABI2 RABGAP1L NPC1L1 RABGEF1 XPO7 | 1.68e-05 | 321 | 115 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | GTPase binding | DOCK1 BICDL2 ERC1 TRIP11 XPO5 ABI2 RABGAP1L NPC1L1 RABGEF1 XPO7 | 4.46e-05 | 360 | 115 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 8.05e-05 | 15 | 115 | 3 | GO:0034483 | |
| GeneOntologyCellularComponent | laminin-11 complex | 8.35e-05 | 3 | 111 | 2 | GO:0043260 | |
| MousePheno | abnormal heart ventricle outflow tract morphology | 2.52e-07 | 96 | 94 | 8 | MP:0010224 | |
| MousePheno | abnormal semilunar valve morphology | 3.89e-06 | 97 | 94 | 7 | MP:0002746 | |
| MousePheno | abnormal atrioventricular valve morphology | 9.88e-05 | 69 | 94 | 5 | MP:0002745 | |
| MousePheno | abnormal heart valve morphology | 1.13e-04 | 163 | 94 | 7 | MP:0000285 | |
| MousePheno | abnormal mesonephros morphology | 1.21e-04 | 72 | 94 | 5 | MP:0008487 | |
| MousePheno | abnormal aortic valve morphology | 1.21e-04 | 72 | 94 | 5 | MP:0002747 | |
| MousePheno | abnormal heart left ventricle outflow tract morphology | 1.21e-04 | 72 | 94 | 5 | MP:0010429 | |
| MousePheno | abnormal heart atrium and ventricle connection | 1.47e-04 | 75 | 94 | 5 | MP:0010435 | |
| Domain | GOLGA6L | 1.96e-08 | 6 | 114 | 4 | IPR026737 | |
| Domain | Heparan_SO4-6-sulfoTrfase | 2.21e-07 | 3 | 114 | 3 | IPR010635 | |
| Domain | GOLGA2L5 | 3.77e-06 | 18 | 114 | 4 | PF15070 | |
| Domain | Golgin_A | 3.77e-06 | 18 | 114 | 4 | IPR024858 | |
| Domain | PAS_9 | 2.58e-05 | 10 | 114 | 3 | PF13426 | |
| Domain | FoP_duplication | 3.69e-05 | 2 | 114 | 2 | SM01218 | |
| Domain | FoP_C | 3.69e-05 | 2 | 114 | 2 | IPR025715 | |
| Domain | FoP_duplication | 3.69e-05 | 2 | 114 | 2 | PF13865 | |
| Domain | SPEC | 4.15e-05 | 32 | 114 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 4.15e-05 | 32 | 114 | 4 | IPR018159 | |
| Domain | Sulfotransfer_2 | 4.68e-05 | 12 | 114 | 3 | PF03567 | |
| Domain | Sulfotransferase | 4.68e-05 | 12 | 114 | 3 | IPR005331 | |
| Domain | PAS | 5.30e-05 | 34 | 114 | 4 | PS50112 | |
| Domain | PAS | 5.30e-05 | 34 | 114 | 4 | IPR000014 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 7.68e-05 | 14 | 114 | 3 | IPR003938 | |
| Domain | CH | 8.37e-05 | 73 | 114 | 5 | PS50021 | |
| Domain | CH-domain | 9.53e-05 | 75 | 114 | 5 | IPR001715 | |
| Domain | DUF3496 | 1.10e-04 | 3 | 114 | 2 | IPR021885 | |
| Domain | K_chnl_volt-dep_ERG | 1.10e-04 | 3 | 114 | 2 | IPR003967 | |
| Domain | DUF3496 | 1.10e-04 | 3 | 114 | 2 | PF12001 | |
| Domain | Spectrin | 3.59e-04 | 23 | 114 | 3 | PF00435 | |
| Domain | ACTININ_2 | 3.59e-04 | 23 | 114 | 3 | PS00020 | |
| Domain | ACTININ_1 | 3.59e-04 | 23 | 114 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.59e-04 | 23 | 114 | 3 | IPR001589 | |
| Domain | ING | 3.65e-04 | 5 | 114 | 2 | SM01408 | |
| Domain | ING_N_histone_binding | 3.65e-04 | 5 | 114 | 2 | IPR024610 | |
| Domain | ING | 3.65e-04 | 5 | 114 | 2 | PF12998 | |
| Domain | ING_fam | 3.65e-04 | 5 | 114 | 2 | IPR028651 | |
| Domain | PAS-assoc_C | 4.08e-04 | 24 | 114 | 3 | IPR000700 | |
| Domain | PAS | 4.62e-04 | 25 | 114 | 3 | PF00989 | |
| Domain | PAS_fold | 4.62e-04 | 25 | 114 | 3 | IPR013767 | |
| Domain | PAC | 5.20e-04 | 26 | 114 | 3 | IPR001610 | |
| Domain | PAC | 5.20e-04 | 26 | 114 | 3 | PS50113 | |
| Domain | PAC | 5.20e-04 | 26 | 114 | 3 | SM00086 | |
| Domain | Kinesin-like | 5.45e-04 | 6 | 114 | 2 | IPR022164 | |
| Domain | DUF3694 | 5.45e-04 | 6 | 114 | 2 | PF12473 | |
| Domain | CH | 6.69e-04 | 65 | 114 | 4 | SM00033 | |
| Domain | Spectrin_repeat | 7.21e-04 | 29 | 114 | 3 | IPR002017 | |
| Domain | CH | 8.85e-04 | 70 | 114 | 4 | PF00307 | |
| Domain | - | 9.34e-04 | 71 | 114 | 4 | 1.10.418.10 | |
| Domain | CNMP_BINDING_1 | 9.66e-04 | 32 | 114 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 9.66e-04 | 32 | 114 | 3 | PS00889 | |
| Domain | PAS | 9.66e-04 | 32 | 114 | 3 | SM00091 | |
| Domain | cNMP | 1.15e-03 | 34 | 114 | 3 | SM00100 | |
| Domain | cNMP_binding | 1.15e-03 | 34 | 114 | 3 | PF00027 | |
| Domain | cNMP-bd_dom | 1.26e-03 | 35 | 114 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 1.26e-03 | 35 | 114 | 3 | PS50042 | |
| Domain | BPI1 | 1.29e-03 | 9 | 114 | 2 | SM00328 | |
| Domain | HTH_MYB | 1.29e-03 | 9 | 114 | 2 | PS51294 | |
| Domain | Myb_dom | 1.29e-03 | 9 | 114 | 2 | IPR017930 | |
| Domain | cNMP-bd-like | 1.60e-03 | 38 | 114 | 3 | IPR018490 | |
| Domain | LBP_BPI_CETP_C | 1.61e-03 | 10 | 114 | 2 | PF02886 | |
| Domain | Lipid-bd_serum_glycop_C | 2.34e-03 | 12 | 114 | 2 | IPR001124 | |
| Domain | LBP_BPI_CETP | 2.76e-03 | 13 | 114 | 2 | PF01273 | |
| Domain | BPI/LBP/Plunc | 2.76e-03 | 13 | 114 | 2 | IPR032942 | |
| Domain | Bactericidal_perm-incr_a/b_dom | 2.76e-03 | 13 | 114 | 2 | IPR017943 | |
| Domain | Lipid-bd_serum_glycop_N | 2.76e-03 | 13 | 114 | 2 | IPR017942 | |
| Domain | - | 3.14e-03 | 48 | 114 | 3 | 2.60.120.10 | |
| Domain | RmlC-like_jellyroll | 3.73e-03 | 51 | 114 | 3 | IPR014710 | |
| Domain | Laminin_N | 4.19e-03 | 16 | 114 | 2 | IPR008211 | |
| Domain | IBN_N | 4.19e-03 | 16 | 114 | 2 | SM00913 | |
| Domain | LamNT | 4.19e-03 | 16 | 114 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 4.19e-03 | 16 | 114 | 2 | PS51117 | |
| Domain | Laminin_N | 4.19e-03 | 16 | 114 | 2 | PF00055 | |
| Domain | Importin-beta_N | 4.73e-03 | 17 | 114 | 2 | IPR001494 | |
| Domain | Ion_trans_dom | 5.25e-03 | 114 | 114 | 4 | IPR005821 | |
| Domain | Ion_trans | 5.25e-03 | 114 | 114 | 4 | PF00520 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KIF13B ERC1 RALGPS2 ANKRD26 LAMC1 TAB2 ITPRID2 STIL TRIP11 ARFGEF3 VPS13D CCDC88A AMOT RABGAP1L SYNE2 MAD1L1 MACF1 PLEKHA5 RABGEF1 CSPP1 PLK4 | 2.03e-12 | 861 | 120 | 21 | 36931259 |
| Pubmed | ERC1 ICE2 TAB2 TRIP11 RABL6 ARFGEF3 CCDC88A SYNE2 PLEKHA5 CSPP1 CCDC93 | 1.29e-09 | 251 | 120 | 11 | 29778605 | |
| Pubmed | 6.56e-09 | 225 | 120 | 10 | 12168954 | ||
| Pubmed | 4.01e-08 | 3 | 120 | 3 | 25643514 | ||
| Pubmed | 4.01e-08 | 3 | 120 | 3 | 15499561 | ||
| Pubmed | Substrate specificities of mouse heparan sulphate glucosaminyl 6-O-sulphotransferases. | 4.01e-08 | 3 | 120 | 3 | 12611590 | |
| Pubmed | 4.01e-08 | 3 | 120 | 3 | 10644753 | ||
| Pubmed | 4.01e-08 | 3 | 120 | 3 | 23223449 | ||
| Pubmed | 4.01e-08 | 3 | 120 | 3 | 16326709 | ||
| Pubmed | 5.84e-08 | 151 | 120 | 8 | 17043677 | ||
| Pubmed | 7.35e-08 | 103 | 120 | 7 | 10574462 | ||
| Pubmed | 1.60e-07 | 4 | 120 | 3 | 15226404 | ||
| Pubmed | 1.60e-07 | 4 | 120 | 3 | 21951307 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | KIF13B NCOA3 ERC1 NIPSNAP1 RALGPS2 TRIP11 GTF3C4 CNOT6 CCDC88A XPO5 AMOT RABGAP1L PLEKHA5 ALYREF RABGEF1 CSPP1 CCDC93 CCDC144A | 6.69e-07 | 1321 | 120 | 18 | 27173435 |
| Pubmed | DOCK1 KRT14 ING5 LAMB2 NCKAP5 ITPRID2 CCDC88A CEP250 KRT20 MACF1 PLEKHA5 | 1.05e-06 | 486 | 120 | 11 | 20936779 | |
| Pubmed | 1.39e-06 | 7 | 120 | 3 | 20410206 | ||
| Pubmed | 2.22e-06 | 8 | 120 | 3 | 17405882 | ||
| Pubmed | 3.31e-06 | 9 | 120 | 3 | 21357686 | ||
| Pubmed | 3.89e-06 | 263 | 120 | 8 | 34702444 | ||
| Pubmed | Bimodal regulation of an Elk subfamily K+ channel by phosphatidylinositol 4,5-bisphosphate. | 4.72e-06 | 10 | 120 | 3 | 26503718 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KIF13B KRT14 ERC1 ANKRD26 TAB2 ITPRID2 TRIP11 ARFGEF3 CCDC88A SUPT6H MACF1 | 6.47e-06 | 588 | 120 | 11 | 38580884 |
| Pubmed | Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. | 6.48e-06 | 11 | 120 | 3 | 15944372 | |
| Pubmed | 6.48e-06 | 11 | 120 | 3 | 23690091 | ||
| Pubmed | DOCK1 ERC1 ICE2 ANKRD26 TAB2 XPNPEP1 RABL6 CCDC88A XPO5 FANCI MACF1 PLEKHA5 | 6.57e-06 | 708 | 120 | 12 | 39231216 | |
| Pubmed | Identification of potential bladder progenitor cells in the trigone. | 8.61e-06 | 12 | 120 | 3 | 24992712 | |
| Pubmed | 8.61e-06 | 12 | 120 | 3 | 12460940 | ||
| Pubmed | ANKRD26 LAMC1 TAB2 TRIP11 SUPT6H AMOT SYNE2 MACF1 RABGEF1 ATP2A1 | 9.27e-06 | 497 | 120 | 10 | 23414517 | |
| Pubmed | 9.34e-06 | 81 | 120 | 5 | 39217171 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 20574624 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 21574103 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 21543057 | ||
| Pubmed | A laminin-like adhesive protein concentrated in the synaptic cleft of the neuromuscular junction. | 1.18e-05 | 2 | 120 | 2 | 2922051 | |
| Pubmed | ANKRD26-RET - A novel gene fusion involving RET in papillary thyroid carcinoma. | 1.18e-05 | 2 | 120 | 2 | 31425920 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 25342035 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 22119824 | ||
| Pubmed | Altered expression of CK7 and CK20 in preneoplastic and neoplastic lesions in ulcerative colitis. | 1.18e-05 | 2 | 120 | 2 | 18092953 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 24563483 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 12492399 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 14631371 | ||
| Pubmed | Aberrant keratin 7 and 20 expression in triple-negative carcinoma of the breast. | 1.18e-05 | 2 | 120 | 2 | 26670478 | |
| Pubmed | CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia. | 1.18e-05 | 2 | 120 | 2 | 17593078 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 11962749 | ||
| Pubmed | Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas. | 1.18e-05 | 2 | 120 | 2 | 21282015 | |
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 15371952 | ||
| Pubmed | 1.18e-05 | 2 | 120 | 2 | 10191308 | ||
| Pubmed | Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. | 1.18e-05 | 2 | 120 | 2 | 35390310 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | KRT14 NIPSNAP1 LAMB2 LAMC1 ITPRID2 SUPT6H AMOT SYNE2 MACF1 ALYREF CDC5L PHIP CHTOP XPO7 | 1.25e-05 | 1024 | 120 | 14 | 24711643 |
| Pubmed | 1.55e-05 | 418 | 120 | 9 | 34709266 | ||
| Pubmed | 2.53e-05 | 49 | 120 | 4 | 31762063 | ||
| Pubmed | ERC1 NIPSNAP1 RALGPS2 ANKRD26 GTF3C4 AMOT PLEKHA5 RABGEF1 CSPP1 | 2.58e-05 | 446 | 120 | 9 | 24255178 | |
| Pubmed | 2.78e-05 | 169 | 120 | 6 | 31462741 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LAMB2 SMG5 EML3 KCNH3 FOCAD RABL6 EHBP1L1 ZNRF3 KCNH2 FANCI MAD1L1 PAXIP1 NLRC5 SNAPC4 | 2.89e-05 | 1105 | 120 | 14 | 35748872 |
| Pubmed | KIF13B NCOA3 ERC1 TRIP11 CCDC88A ABI2 SYNE2 MAD1L1 MACF1 PLEKHA5 ALYREF RABGEF1 CDC5L | 2.96e-05 | 963 | 120 | 13 | 28671696 | |
| Pubmed | 3.09e-05 | 255 | 120 | 7 | 15324660 | ||
| Pubmed | Mapping interactions between mRNA export factors in living cells. | 3.53e-05 | 3 | 120 | 2 | 23826332 | |
| Pubmed | Multiple exportins influence thyroid hormone receptor localization. | 3.53e-05 | 3 | 120 | 2 | 25911113 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 14643686 | ||
| Pubmed | Direct binding of CEP85 to STIL ensures robust PLK4 activation and efficient centriole assembly. | 3.53e-05 | 3 | 120 | 2 | 29712910 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 35074964 | ||
| Pubmed | Loss of Rad51c accelerates tumourigenesis in sebaceous glands of Trp53-mutant mice. | 3.53e-05 | 3 | 120 | 2 | 25270124 | |
| Pubmed | Superficial cell differentiation during embryonic and postnatal development of mouse urothelium. | 3.53e-05 | 3 | 120 | 2 | 16973199 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 26820992 | ||
| Pubmed | Direct interaction between CEP85 and STIL mediates PLK4-driven directed cell migration. | 3.53e-05 | 3 | 120 | 2 | 32107292 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 21177815 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 30197118 | ||
| Pubmed | CDK1 Prevents Unscheduled PLK4-STIL Complex Assembly in Centriole Biogenesis. | 3.53e-05 | 3 | 120 | 2 | 27112295 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 22895272 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 7698745 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 22361037 | ||
| Pubmed | Potassium Ion Channel Protein (KCNH) Levels in Patients with Fibromyalgia Syndrome. | 3.53e-05 | 3 | 120 | 2 | 35818223 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 10481268 | ||
| Pubmed | Cell-cycle-regulated expression of STIL controls centriole number in human cells. | 3.53e-05 | 3 | 120 | 2 | 22349698 | |
| Pubmed | Integrins regulate hERG1 dynamics by girdin-dependent Gαi3: signaling and modeling in cancer cells. | 3.53e-05 | 3 | 120 | 2 | 37923359 | |
| Pubmed | Sequencing of laminin B chain cDNAs reveals C-terminal regions of coiled-coil alpha-helix. | 3.53e-05 | 3 | 120 | 2 | 6209134 | |
| Pubmed | HERG K(+) currents in human prolactin-secreting adenoma cells. | 3.53e-05 | 3 | 120 | 2 | 12634931 | |
| Pubmed | The PLK4-STIL-SAS-6 module at the core of centriole duplication. | 3.53e-05 | 3 | 120 | 2 | 27911707 | |
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 22268990 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 39078783 | ||
| Pubmed | 3.53e-05 | 3 | 120 | 2 | 34853972 | ||
| Pubmed | CDX2, cytokeratins 7 and 20 immunoreactivity in rectal adenocarcinoma. | 3.53e-05 | 3 | 120 | 2 | 19098678 | |
| Pubmed | Laminin-121--recombinant expression and interactions with integrins. | 3.53e-05 | 3 | 120 | 2 | 20566382 | |
| Pubmed | 3.81e-05 | 469 | 120 | 9 | 27634302 | ||
| Pubmed | 3.97e-05 | 363 | 120 | 8 | 25036637 | ||
| Pubmed | Centriole signaling restricts hepatocyte ploidy to maintain liver integrity. | 7.05e-05 | 4 | 120 | 2 | 35981754 | |
| Pubmed | Laminins 411 and 421 differentially promote tumor cell migration via α6β1 integrin and MCAM (CD146). | 7.05e-05 | 4 | 120 | 2 | 24951930 | |
| Pubmed | Regulation and Function of Laminin A5 during Mouse and Human Decidualization. | 7.05e-05 | 4 | 120 | 2 | 35008625 | |
| Pubmed | Hbo1 Links p53-dependent stress signaling to DNA replication licensing. | 7.05e-05 | 4 | 120 | 2 | 17954561 | |
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 22349705 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 23074159 | ||
| Pubmed | p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. | 7.05e-05 | 4 | 120 | 2 | 12750254 | |
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 28849223 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 23281850 | ||
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 15086023 | ||
| Pubmed | STIL binding to Polo-box 3 of PLK4 regulates centriole duplication. | 7.05e-05 | 4 | 120 | 2 | 26188084 | |
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 29104277 | ||
| Pubmed | Changes in laminin isoforms associated with brain tumor invasion and angiogenesis. | 7.05e-05 | 4 | 120 | 2 | 16146715 | |
| Pubmed | 7.05e-05 | 4 | 120 | 2 | 8034675 | ||
| Pubmed | RAD51C BPIFB1 SMG5 ITPRID2 TRIP11 GTF3C4 XPO5 FANCI MACF1 XPO7 | 7.27e-05 | 634 | 120 | 10 | 34591612 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 7.51e-05 | 202 | 120 | 6 | 33005030 | |
| Pubmed | 7.69e-05 | 24 | 120 | 3 | 34653670 | ||
| Interaction | YWHAH interactions | KIF13B NCOA3 ERC1 RALGPS2 ANKRD26 TAB2 ITPRID2 STIL TRIP11 EML3 ARFGEF3 SLX9 VPS13D CCDC88A ABI2 KCNH2 AMOT RABGAP1L SYNE2 MAD1L1 CC2D2A MACF1 PLEKHA5 RABGEF1 ARL14EP CSPP1 PLK4 | 1.61e-10 | 1102 | 118 | 27 | int:YWHAH |
| Interaction | YWHAG interactions | KIF13B ERC1 RALGPS2 ANKRD26 TAB2 ITPRID2 TRIP11 EML3 VPS13D CCDC88A AMOT CEP250 RABGAP1L SYNE2 MAD1L1 ING4 MACF1 PLEKHA5 RABGEF1 ARL14EP CDC5L CSPP1 PLK4 | 8.02e-07 | 1248 | 118 | 23 | int:YWHAG |
| Interaction | SASS6 interactions | 4.42e-06 | 159 | 118 | 8 | int:SASS6 | |
| Interaction | CCHCR1 interactions | TRIML2 ING5 TSGA10 ABI2 RABGAP1L MAD1L1 RABGEF1 GOLGA6L9 CCDC93 | 8.25e-06 | 229 | 118 | 9 | int:CCHCR1 |
| Interaction | DISC1 interactions | TSGA10 LAMC1 XPNPEP1 STIL TRIP11 CCDC88A ABI2 AMOT MACF1 ALYREF CDC5L SPATC1L | 8.28e-06 | 429 | 118 | 12 | int:DISC1 |
| Interaction | PCM1 interactions | FAM184B KRT14 ERC1 ING5 ANKRD26 SMG5 ITPRID2 STIL ABI2 CEP250 CC2D2A CSPP1 | 9.30e-06 | 434 | 118 | 12 | int:PCM1 |
| Interaction | MIB1 interactions | 9.39e-06 | 295 | 118 | 10 | int:MIB1 | |
| Interaction | NDC80 interactions | ERC1 ANKRD26 FOCAD XPO5 AMOT CEP250 SYNE2 MAD1L1 CDC5L CSPP1 | 1.53e-05 | 312 | 118 | 10 | int:NDC80 |
| Interaction | EXOC1 interactions | 2.14e-05 | 143 | 118 | 7 | int:EXOC1 | |
| Interaction | VPS33B interactions | 2.27e-05 | 199 | 118 | 8 | int:VPS33B | |
| Interaction | YWHAQ interactions | KIF13B NCOA3 ERC1 RALGPS2 ANKRD26 TAB2 ITPRID2 TRIP11 EML3 VPS13D CCDC88A CEP250 MACF1 CD74 PLEKHA5 RABGEF1 ARL14EP CDC5L PLK4 | 2.60e-05 | 1118 | 118 | 19 | int:YWHAQ |
| Interaction | NUP62 interactions | 3.32e-05 | 273 | 118 | 9 | int:NUP62 | |
| Interaction | KCNH4 interactions | 4.14e-05 | 12 | 118 | 3 | int:KCNH4 | |
| Interaction | SFN interactions | KIF13B RALGPS2 ANKRD26 TAB2 ITPRID2 TRIP11 CCDC88A AMOT RABGAP1L MACF1 PLEKHA5 RABGEF1 PLK4 CHTOP | 5.37e-05 | 692 | 118 | 14 | int:SFN |
| Interaction | GARRE1 interactions | 5.77e-05 | 167 | 118 | 7 | int:GARRE1 | |
| Interaction | SNAPIN interactions | 6.22e-05 | 169 | 118 | 7 | int:SNAPIN | |
| Interaction | INSYN1 interactions | 6.22e-05 | 169 | 118 | 7 | int:INSYN1 | |
| Interaction | YWHAZ interactions | KIF13B ERC1 HS6ST2 RALGPS2 ANKRD26 LAMC1 TAB2 ITPRID2 EML3 VPS13D CCDC88A ABI2 SYNE2 MACF1 CD74 PLEKHA5 RABGEF1 ARL14EP CDC5L PLK4 | 7.74e-05 | 1319 | 118 | 20 | int:YWHAZ |
| Interaction | YWHAB interactions | KIF13B ERC1 RALGPS2 ANKRD26 ITPRID2 TRIP11 EML3 VPS13D CCDC88A ABI2 AMOT MACF1 CD74 PLEKHA5 RABGEF1 ARL14EP PLK4 | 8.55e-05 | 1014 | 118 | 17 | int:YWHAB |
| Interaction | PCNT interactions | 8.79e-05 | 241 | 118 | 8 | int:PCNT | |
| Interaction | KRT75 interactions | 9.57e-05 | 181 | 118 | 7 | int:KRT75 | |
| Interaction | FBXO42 interactions | 1.45e-04 | 259 | 118 | 8 | int:FBXO42 | |
| Interaction | PHLDB3 interactions | 1.51e-04 | 86 | 118 | 5 | int:PHLDB3 | |
| Interaction | ATF7IP interactions | 1.63e-04 | 138 | 118 | 6 | int:ATF7IP | |
| Interaction | METTL21C interactions | 1.77e-04 | 19 | 118 | 3 | int:METTL21C | |
| Interaction | JADE2 interactions | 1.78e-04 | 48 | 118 | 4 | int:JADE2 | |
| Interaction | PLEC interactions | KRT14 SPEF2 NIPSNAP1 TSGA10 CCDC88A SYNE2 MACF1 PLEKHA5 CDC5L SPATC1L | 2.21e-04 | 430 | 118 | 10 | int:PLEC |
| Interaction | WASHC1 interactions | 2.29e-04 | 94 | 118 | 5 | int:WASHC1 | |
| Interaction | LINC02910 interactions | 2.41e-04 | 95 | 118 | 5 | int:LINC02910 | |
| Interaction | CEP350 interactions | 2.46e-04 | 149 | 118 | 6 | int:CEP350 | |
| Interaction | TRAF3IP1 interactions | 2.53e-04 | 96 | 118 | 5 | int:TRAF3IP1 | |
| Interaction | KRT19 interactions | 2.58e-04 | 282 | 118 | 8 | int:KRT19 | |
| Interaction | KRT24 interactions | 2.82e-04 | 54 | 118 | 4 | int:KRT24 | |
| Interaction | CEP250 interactions | 2.90e-04 | 287 | 118 | 8 | int:CEP250 | |
| Interaction | OIP5 interactions | 2.92e-04 | 217 | 118 | 7 | int:OIP5 | |
| Cytoband | 15q25.2 | 1.94e-04 | 43 | 119 | 3 | 15q25.2 | |
| GeneFamily | Exportins | 2.81e-04 | 7 | 67 | 2 | 547 | |
| GeneFamily | Sulfotransferases, membrane bound | 3.45e-04 | 37 | 67 | 3 | 763 | |
| GeneFamily | Potassium voltage-gated channels | 4.36e-04 | 40 | 67 | 3 | 274 | |
| GeneFamily | Laminin subunits | 8.72e-04 | 12 | 67 | 2 | 626 | |
| GeneFamily | BPI fold containing | 1.57e-03 | 16 | 67 | 2 | 456 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.77e-03 | 17 | 67 | 2 | 486 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 2.46e-03 | 20 | 67 | 2 | 548 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.84e-03 | 25 | 67 | 2 | 775 | |
| GeneFamily | Keratins, type I | 4.81e-03 | 28 | 67 | 2 | 608 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | NCOA3 ERC1 ICE2 RALGPS2 ANKRD26 TAB2 AZI2 MFN1 CCDC88A HECTD2 CEP250 SYNE2 CC2D2A MACF1 PLEKHA5 ARL14EP SNAPC4 PHIP | 2.05e-07 | 780 | 115 | 18 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.04e-08 | 157 | 119 | 8 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-06 | 181 | 119 | 6 | a5e770b5b5d57cbac18560828e89f7c96b687743 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-06 | 181 | 119 | 6 | 504b1af1951a7a20ef5db69d84c20630ec64095b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-06 | 181 | 119 | 6 | a55ec36d2393f7a376feb42b22aee75dfdf4c383 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-06 | 181 | 119 | 6 | a93df1ba23d5b5f249491d69d12bfc0e274dafcf | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 191 | 119 | 6 | 39ef8e1d7cc3ebb11717e8a55501515e3b72b177 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 192 | 119 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-05 | 198 | 119 | 6 | af682919a874d60f579e854c274dc47063015ea9 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 1.59e-05 | 199 | 119 | 6 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.59e-05 | 199 | 119 | 6 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.64e-05 | 200 | 119 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-9|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.02e-05 | 134 | 119 | 5 | 2647453f44b0e0a8f27ef9bba750e99eb40efc8b | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.02e-05 | 149 | 119 | 5 | 58c1ac5a46898021224b9cb1483a0c58554bc4fb | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_2|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.06e-05 | 155 | 119 | 5 | 92dc029ed8b197b2d3ab73719a36545d86b26cb1 | |
| ToppCell | VE-Treg-naive_CD4|VE / Condition, Cell_class and T cell subcluster | 6.24e-05 | 156 | 119 | 5 | 6501baf73616e702946de9fb13d267e30a68888b | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-05 | 157 | 119 | 5 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-05 | 161 | 119 | 5 | 140b3c7077947c541cff54f6754e2df968345f4d | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.68e-05 | 163 | 119 | 5 | bca9abd02ffb2a90c8386a59f5e25126ae7b6acd | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.37e-05 | 166 | 119 | 5 | 4b31d2755108b2815316411a38bfb11fd30ef98a | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Pvalb_(Non-anterior_nuclei)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 8.74e-05 | 87 | 119 | 4 | fd0df79b02f96463a6bad90dcd019c59c8e3eb0e | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.86e-05 | 168 | 119 | 5 | 63437b3c3a66f953eaed600965ab193f9cc49da2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 169 | 119 | 5 | 44d841fd997a6f26104f16cd00223ecce8352f43 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 169 | 119 | 5 | 0f5e737b265ba333275a0cd289dab029a1542075 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 169 | 119 | 5 | aec1b4c7e973a31c53aaea47c2c05d24ce16aa4f | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.90e-05 | 172 | 119 | 5 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 172 | 119 | 5 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | ILEUM-inflamed-(4)_Mast|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.90e-05 | 172 | 119 | 5 | be82f749f4b1049ae8832facc052082cf5463c11 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 172 | 119 | 5 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.90e-05 | 172 | 119 | 5 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | ILEUM-inflamed-(4)_Mast_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.90e-05 | 172 | 119 | 5 | 7185b28282412f3a464b2a8ad5605475a1a31358 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 173 | 119 | 5 | a7dee23b1d43d3070d502487af319ff81a9a747b | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Cycling_pre-Lymphocytic-T|bone_marrow / Manually curated celltypes from each tissue | 1.04e-04 | 174 | 119 | 5 | 1e289b26e2c29dbad15b712a999b96c391a26129 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 174 | 119 | 5 | dc4298c1d9359f7e37454e9451f889017227d5cf | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 176 | 119 | 5 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 176 | 119 | 5 | 0d203682c372411ba64e97a8eae6c4788e8b6ecf | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Promyelocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.10e-04 | 176 | 119 | 5 | ee33d7077a92c1fd371081e7c990c7266e711957 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-04 | 177 | 119 | 5 | 164ffbbf798defa3728197deb1a14b661490e525 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 177 | 119 | 5 | 43883b65b1e03043a24fc40c84c50bac81960c12 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 177 | 119 | 5 | 9de6a82b7fb72d20361947f7ac95bb1fa73fc2ff | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.13e-04 | 177 | 119 | 5 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-04 | 178 | 119 | 5 | c85de851b39cb8ef7ea1866ab64c6a387788273a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-04 | 179 | 119 | 5 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.19e-04 | 179 | 119 | 5 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 179 | 119 | 5 | 13d80ae2e43a5daad0aeb5f47338efca2c58800a | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.22e-04 | 180 | 119 | 5 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-04 | 180 | 119 | 5 | 2658a6be43d6d94767b4fc5af2d8632469a8a979 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-04 | 182 | 119 | 5 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-04 | 182 | 119 | 5 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.32e-04 | 183 | 119 | 5 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-04 | 183 | 119 | 5 | cff3197e9ff401362501db2317c86adc6d24b595 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-04 | 183 | 119 | 5 | f803dd2881ceaed6327e21a1a51bc3d3ccf4b5f8 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-04 | 183 | 119 | 5 | 4bd6883daf2dbe8c1b49b776b48d41f9890d1cb4 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.32e-04 | 183 | 119 | 5 | 6e5b39c0170d62eb7fdd411dcfff51ed176573d0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.32e-04 | 183 | 119 | 5 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-04 | 185 | 119 | 5 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.39e-04 | 185 | 119 | 5 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-04 | 185 | 119 | 5 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.39e-04 | 185 | 119 | 5 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.39e-04 | 185 | 119 | 5 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.39e-04 | 185 | 119 | 5 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.39e-04 | 185 | 119 | 5 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.39e-04 | 185 | 119 | 5 | 7a3612520ae4f0cd61480eadba31eecce001419d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.43e-04 | 186 | 119 | 5 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.43e-04 | 186 | 119 | 5 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 186 | 119 | 5 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Pulmonary_neuroendocrine|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.43e-04 | 186 | 119 | 5 | fcabebdfbf1b1dbb35ce2b3c53a60d2b1aed8e6c | |
| ToppCell | moderate-Epithelial-Ionocyte|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.46e-04 | 187 | 119 | 5 | 3e3fe2d5712a0ac477cddefe56705d4b8d8f7eac | |
| ToppCell | Control-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 1.46e-04 | 187 | 119 | 5 | 3a032432f780525f4f4c2a358897d9989b1ecae7 | |
| ToppCell | moderate-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.54e-04 | 189 | 119 | 5 | 6011b747e27d61d222380a7bffdd921a68e9b657 | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.58e-04 | 190 | 119 | 5 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | critical-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.58e-04 | 190 | 119 | 5 | 05a2c3549b68f49081723bf35db14974274419d5 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B1|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 190 | 119 | 5 | 2434b8ad2976eab7d9147012c28454ab29670709 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 190 | 119 | 5 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 191 | 119 | 5 | a15e34ad7dbf3f2f13d5e23ce3ffb6d08fd1f9f0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 191 | 119 | 5 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.62e-04 | 191 | 119 | 5 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-04 | 192 | 119 | 5 | b9d6cf6068ffa104968f4944cbf8af6faa2b8942 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-04 | 192 | 119 | 5 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.65e-04 | 192 | 119 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 193 | 119 | 5 | 9f69edc97b868d23998abc98928a2e89a885ef8a | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-MPO+_mono-neutrophil|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-04 | 193 | 119 | 5 | 35998200890fef12e7f4a3dc65eca1c30d19fa93 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.70e-04 | 193 | 119 | 5 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | B_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.70e-04 | 193 | 119 | 5 | b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155 | |
| ToppCell | C_06|World / shred on cell type and cluster | 1.74e-04 | 194 | 119 | 5 | 5cb42e09f380c4468cdc603ec0c3de35eadd3213 | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.74e-04 | 194 | 119 | 5 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 194 | 119 | 5 | 7c7091de47359760003e910cfbe63db5c99410d6 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-04 | 194 | 119 | 5 | 8e2819a9d0529f7b2de1a7c1190575175d6173ee | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 194 | 119 | 5 | 48c37251518f96524807b5bd1bbc2820637666ad | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.74e-04 | 194 | 119 | 5 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.74e-04 | 194 | 119 | 5 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 194 | 119 | 5 | 7b6a34d1f8922b71dcc931421666c1822cec8345 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-04 | 194 | 119 | 5 | 435406ebe626c702f7d5a99a3d68ee85aa09be95 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.74e-04 | 194 | 119 | 5 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.78e-04 | 195 | 119 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-B_cells-LZ_GC_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.78e-04 | 195 | 119 | 5 | cccc9c70bb8f6df8c6ab94534c17475af1d3e224 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.78e-04 | 195 | 119 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-04 | 195 | 119 | 5 | 3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.78e-04 | 195 | 119 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 195 | 119 | 5 | ba7cb80deb872c9184769f0dd57855c3c6a432bf | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-04 | 195 | 119 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 8.36e-07 | 197 | 117 | 9 | 1148_DN | |
| Drug | Erythromycin [114-07-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 7.71e-06 | 195 | 117 | 8 | 5329_UP | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; HL60; HT_HG-U133A | 8.00e-06 | 196 | 117 | 8 | 1315_DN | |
| Drug | WAY-123,398 | 1.55e-05 | 10 | 117 | 3 | CID000132160 | |
| Drug | N-(1-(2,3-dimethoxyphenyl)-4-methyl-3-penten-1-yl)-1-(5-bromofurfuryl)-1-piperidyl-4-amine | 2.62e-05 | 2 | 117 | 2 | ctd:C531033 | |
| Drug | EGDA | 5.75e-05 | 15 | 117 | 3 | CID000008121 | |
| Drug | Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A | 5.77e-05 | 190 | 117 | 7 | 6718_DN | |
| Drug | Phensuximide [86-34-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 6.58e-05 | 194 | 117 | 7 | 3521_DN | |
| Drug | Methylergometrine maleate [113-42-8]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 6.58e-05 | 194 | 117 | 7 | 5303_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.80e-05 | 195 | 117 | 7 | 6979_DN | |
| Drug | Tolfenamic acid [13710-19-5]; Down 200; 15.2uM; PC3; HT_HG-U133A | 7.02e-05 | 196 | 117 | 7 | 6354_DN | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 117 | 7 | 2892_DN | |
| Drug | DNA-PK Inhibitor III; Down 200; 1uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 117 | 7 | 7543_DN | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 117 | 7 | 2768_DN | |
| Drug | Tobramycin [32986-56-4]; Down 200; 8.6uM; HL60; HT_HG-U133A | 7.25e-05 | 197 | 117 | 7 | 2481_DN | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Up 200; 8.2uM; PC3; HT_HG-U133A | 7.49e-05 | 198 | 117 | 7 | 5868_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A | 7.49e-05 | 198 | 117 | 7 | 5837_UP | |
| Drug | Reserpine [50-55-5]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 7.73e-05 | 199 | 117 | 7 | 3341_DN | |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; HL60; HG-U133A | 7.73e-05 | 199 | 117 | 7 | 1557_DN | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; HL60; HG-U133A | 7.73e-05 | 199 | 117 | 7 | 1738_DN | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Down 200; 12.2uM; HL60; HT_HG-U133A | 7.73e-05 | 199 | 117 | 7 | 3011_DN | |
| Drug | ksc-8-189 | 7.83e-05 | 3 | 117 | 2 | CID000001400 | |
| Disease | short QT syndrome (implicated_via_orthology) | 4.51e-05 | 3 | 115 | 2 | DOID:0050793 (implicated_via_orthology) | |
| Disease | squamous cell carcinoma (implicated_via_orthology) | 4.51e-05 | 3 | 115 | 2 | DOID:1749 (implicated_via_orthology) | |
| Disease | heart conduction disease (implicated_via_orthology) | 2.63e-04 | 32 | 115 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | arabitol measurement | 3.12e-04 | 7 | 115 | 2 | EFO_0800148 | |
| Disease | vital capacity | NCOA3 FAM184B BEST1 ERC1 RALGPS2 TPRX2 TRIP11 EML3 KCNH3 HOXA3 MAD1L1 CDC5L SNAPC4 CCDC171 | 3.28e-04 | 1236 | 115 | 14 | EFO_0004312 |
| Disease | melanoma (implicated_via_orthology) | 4.15e-04 | 8 | 115 | 2 | DOID:1909 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 4.32e-04 | 702 | 115 | 10 | C0009402 | |
| Disease | long QT syndrome (implicated_via_orthology) | 6.64e-04 | 10 | 115 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | PR interval | 7.32e-04 | 495 | 115 | 8 | EFO_0004462 | |
| Disease | Fanconi anemia | 1.33e-03 | 14 | 115 | 2 | cv:C0015625 | |
| Disease | Meckel-Gruber syndrome | 1.53e-03 | 15 | 115 | 2 | C0265215 | |
| Disease | caffeine measurement | 1.53e-03 | 15 | 115 | 2 | EFO_0021177 | |
| Disease | Bone marrow hypocellularity | 2.21e-03 | 18 | 115 | 2 | C1855710 | |
| Disease | Meckel syndrome type 1 | 2.21e-03 | 18 | 115 | 2 | C3714506 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 2.47e-03 | 19 | 115 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 2.47e-03 | 144 | 115 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | albumin:globulin ratio measurement | 2.94e-03 | 73 | 115 | 3 | EFO_0005128 | |
| Disease | Malignant neoplasm of breast | RAD51C NCOA3 KRT14 MCF2L2 HOXA3 UNC45B SYNE2 NLRC5 MACF1 CD74 HSD17B8 | 3.20e-03 | 1074 | 115 | 11 | C0006142 |
| Disease | Primary microcephaly | 3.31e-03 | 22 | 115 | 2 | C0431350 | |
| Disease | alcohol consumption measurement | DOCK1 TNFSF13 FAM114A2 LGALS12 NCKAP5 SPTBN5 MMEL1 ABI2 RABGAP1L MAD1L1 HS6ST3 XPO7 | 3.35e-03 | 1242 | 115 | 12 | EFO_0007878 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LQLRTEVETQQVMRN | 136 | Q9H6S1 | |
| QMVEILSDENRNLRQ | 436 | Q4VCS5 | |
| RILQEAQNLMALTNV | 361 | Q99459 | |
| ILNLNNISSDRIQLM | 396 | Q8TDL5 | |
| DIRQMSQQQDLLSAL | 436 | Q7RTX7 | |
| NLTDSNLQNRIRDQM | 506 | Q9NQ75 | |
| LQELSSNDMLLLQLR | 31 | Q8N8R7 | |
| LLSQTQREQMSLLAA | 716 | Q6TFL3 | |
| LLQSLLNEMNTLRTQ | 206 | O76090 | |
| SQLENRILNQTADML | 156 | Q9UKU9 | |
| RLSQLQSENMLLRQQ | 851 | Q8IYA2 | |
| RENSSNILDNLLSRM | 806 | P16066 | |
| LSQLQSENMLLRQQL | 1136 | Q9UPS8 | |
| NALNSLSENQSLLRM | 911 | O14983 | |
| NVLQMLDIQASQLRR | 71 | Q9NYB9 | |
| SLRTRLLNGLAQQMI | 256 | O43502 | |
| QMTIQALQDELRIQR | 226 | Q8IUD2 | |
| RETLLRQLETNQLDM | 236 | Q3YEC7 | |
| LLSQLNERQERIMNE | 416 | Q9UJ41 | |
| QVLQMREGLQSLRQA | 891 | Q9ULD8 | |
| QIDRLDFIRNQMNLL | 376 | Q8IWA4 | |
| RTLRNITNNADIQQM | 336 | Q6ZW49 | |
| DVLRRNSQLANSVMQ | 611 | Q9NVI1 | |
| NLQRAISRNLMQRAS | 331 | Q96QS6 | |
| QQSMQLEERAEQIRS | 46 | Q9Y6D9 | |
| RVEMANLLNLTERQI | 221 | O43365 | |
| NEISEMNRAIQRLQA | 306 | P08729 | |
| HLEQQNDLLQMIRRS | 246 | Q69YI7 | |
| NDLLQMIRRSQEVQA | 251 | Q69YI7 | |
| RTMQNLEIELQSQLS | 336 | P02533 | |
| RMQAQQALLLESLRQ | 721 | Q9ULE4 | |
| RDSEQQMINIARQSL | 386 | Q5U5R9 | |
| QRQLNRLETRLSADM | 1046 | Q12809 | |
| LEQLQAQMNRLESRV | 826 | Q9H252 | |
| IQTLMLQNRTLLEQN | 1331 | Q3V6T2 | |
| NLNQLENVTTMERLL | 281 | Q86YR7 | |
| SMNQQALEQLRELRI | 311 | Q96DT0 | |
| NIRLDSVSLRMQQDL | 391 | Q5KU26 | |
| NLITDLNRMHRQNID | 686 | Q1MSJ5 | |
| QRLMSASNSNELLLN | 21 | A1E959 | |
| NALIRRQDQLQLLME | 1416 | Q8N3D4 | |
| LEARMRSVLQAINLQ | 1776 | P55268 | |
| NNQMLSLLNRRQEER | 186 | A6NEY3 | |
| NNQMLSLLNRRQEER | 186 | A6NEF3 | |
| NNQMLSLLNRRQEER | 186 | A6NEM1 | |
| NNQMLSLLNRRQEER | 186 | A6NI86 | |
| NNQMLSLLNRRQEER | 186 | H0YKK7 | |
| LERQLALMNSQFNRR | 216 | Q495T6 | |
| LLSSLEAQLMQIRSN | 331 | P35900 | |
| NTFQELQVMRRSLNL | 956 | P28290 | |
| ANNRQVRMLADLSLV | 246 | O60243 | |
| ANNRQVRMLADLSLV | 306 | Q8IZP7 | |
| IINENQRVSMSRNIE | 61 | Q96PD4 | |
| QMTCLQSLRLNRNSI | 1576 | Q86WI3 | |
| QDLSPQQNRQMLRLL | 3561 | Q9UPN3 | |
| MLRLLNELQRSFQDI | 3571 | Q9UPN3 | |
| NRRLQEASMRLEQEN | 16 | B7ZAP0 | |
| NNRTLLLLTANQTLM | 496 | Q9UHC9 | |
| SILQNLRALVAMNEN | 381 | Q567U6 | |
| ANSRSLSQILMEQLQ | 451 | Q659A1 | |
| EVARTNQNIMENRLL | 321 | Q9P2K1 | |
| RSNTSLLQQNLRQLM | 626 | Q14185 | |
| SEMQIQDQSLLLTLR | 46 | A1L168 | |
| MASQLQNRLRSALAL | 1 | Q92506 | |
| MLSDLTLQLRQRQEN | 166 | Q5TH69 | |
| MARLTESEARRQQQQ | 1 | Q8N6W0 | |
| SIRQQELSALRQDMQ | 1076 | Q9BV73 | |
| NQLQMATSLDRLLSL | 371 | Q8NFQ5 | |
| RTRLESLQGENQMLQ | 196 | A1A5D9 | |
| NQMLQSRRQDLEAQI | 206 | A1A5D9 | |
| LMNRNATLSQVLREA | 201 | Q9NRY5 | |
| LQRNFQLMRELDQRT | 21 | Q8WYH8 | |
| DLLQLLESQMQERNN | 456 | P04839 | |
| ANNRQVRMLSDLTLV | 386 | Q96MM7 | |
| DQNLMDRLQRVNNTL | 1096 | P11047 | |
| NQRTIQNDIMLLQLS | 101 | P08311 | |
| LQSLSQRLRVQEQEM | 16 | Q32P44 | |
| LQQQLQEVLGRSLSM | 681 | Q5T1A1 | |
| LTVTSQNLQLENLRM | 81 | P04233 | |
| RLSQLQSENMLLRQQ | 1041 | A2RUR9 | |
| TDNILTNNQTLRLLM | 146 | Q5T4B2 | |
| MVSLRELHLNNNLLR | 96 | Q9ULM6 | |
| SRQQLALNLLEMIQQ | 376 | Q5VW36 | |
| LQRNFQLMRDLDQRT | 21 | Q9UNL4 | |
| EQRSNLMNNILRIIS | 226 | Q86X27 | |
| LMNNILRIISDLQQS | 231 | Q86X27 | |
| ELTEMRLQDQQLARQ | 126 | Q96KS9 | |
| SQMLLSRRNQLLLEF | 156 | Q9BPW8 | |
| EATLNNSLMRLREQI | 676 | Q9NQT8 | |
| QRLTNLRLQNMKSDT | 121 | Q9C093 | |
| RDMAQLRLQLEVSQL | 826 | Q9UPR3 | |
| LQMQLNTSIDLRTNV | 3236 | Q8WXH0 | |
| EMQQLRSCNRQLQID | 591 | Q9NYJ8 | |
| LLRLHLNSNRLQMIN | 166 | Q9H3W5 | |
| LESERNRIQMRSLQQ | 96 | O14513 | |
| LNAQMVAQRSRELLS | 1221 | Q9Y6Q9 | |
| QALRLQLQQEMELLN | 796 | Q9H2K8 | |
| ANMNATIRRIDQLTN | 171 | Q9NP59 | |
| LLQAQARERTLAMQA | 96 | Q8NA69 | |
| DLTLSNLLLTRNMNI | 136 | O00444 | |
| KENQMLRRLLSQSCQ | 26 | Q9H0A9 | |
| QAMLQELLVSAQRLR | 2476 | Q9NRC6 | |
| QLASARNRRLAQQME | 46 | Q9Y3Y2 | |
| EQLQRTQSQLLQMVL | 456 | Q8N1N0 | |
| QNNTRLESRTQLVTM | 1006 | Q7KZ85 | |
| MRLRLLNEECEQNLQ | 111 | Q8N7C3 | |
| QNFQEMLRRLNTSIQ | 111 | Q8IWX7 | |
| LQAQIQRLLEAQSLM | 736 | Q15468 | |
| TSELLRQLRQAMRNS | 6 | Q9NQW7 | |
| MIQRLQQEQDLRRSG | 646 | Q8WWQ0 | |
| DLQLQLEQLRGRTTM | 981 | A6NE52 | |
| RDIQQTLTQNMERIF | 176 | Q9HAV4 | |
| SELSRMSAAQRQQLL | 176 | Q9NSI2 | |
| TMDNRLTIQANLNRL | 186 | Q9UKN8 | |
| DMLRENRSLQSLNIE | 246 | Q9NZQ9 | |
| LVLNRNLSISENRTM | 356 | P07949 | |
| RISMQNLEALLVANR | 561 | Q9BZW7 | |
| SRIRNELMQSLNQDS | 621 | Q15643 | |
| RVLQLMNLTDSRLAQ | 526 | Q9UIA9 | |
| RSQNSMNRLAVQALE | 246 | Q9ULT6 | |
| LLLAQNREQQEELMR | 106 | Q5SXM2 | |
| ADRVIQRTNSMQQLE | 401 | Q9HAU0 | |
| MALLTQQTELQSLRR | 46 | O75888 | |
| LNLAEMLSLREQQLQ | 51 | P0DV77 | |
| MNIQLVTSQIDAQRR | 176 | Q86V81 | |
| QQLMLRLSENREQLE | 4371 | Q5THJ4 |